Glycosmedia

Diabetes News Service

Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookies Policy
  • News
  • Archive
  • Categories & Tags
  • Journal Watch
  • Updates
  • Education
  • Reviews
  • About us ▼
    • About Glycosmedia
    • Editorial Team
    • Frequently asked questions
    • Comments
    • Press Releases
    • Disclaimer
  • Subscribe
  • Contact

Diabetes News

Tag: mortality


Trends in predominant causes of death in individuals with and without diabetes in England from 2001 to 2018: an epidemiological analysis of linked primary care records

February 6th 2021

The decline in vascular death rates has been accompanied by a diversification of causes in individuals with diagnosed diabetes and a transition from vascular diseases to cancers as the leading contributor to diabetes-related death. Clinical and preventative approaches must reflect this trend to reduce the excess mortality risk in individuals with diabetes (Lancet Diabetes & Endocrinology)

Categories: News, Pathology
Tags: cancer, mortality

Categories: Pathology
Tags: cancer, mortality

Potential Unrealized Mortality Benefit of GLP‐1 Receptor Agonists and SGLT2 Inhibitors

September 10th 2020

This analysis indicates unrealized opportunities to reduce mortality in selected Veterans with T2D and CAD via increased use of GLP‐1RA and SGLT2i (Diabetes, Obesity and Metabolism)

Categories: Medication, News
Tags: GLP‐1RA, mortality, SGLT2 inhibitors

Categories: Medication
Tags: GLP‐1RA, mortality, SGLT2 inhibitors

Organisation of primary diabetes care in people with type 2 diabetes in relation to all-cause mortality: a nationwide register-based cohort study

July 23rd 2020

This nationwide register-based cohort study suggests that the number of WTE GPs devoted to diabetes care have an impact on the risk of early death in people with T2DM (Diabetes Research and Clinical Practice)

Categories: Management, News
Tags: mortality, primary care, Type 2 Diabetes

Categories: Management
Tags: mortality, primary care, Type 2 Diabetes

Pain in Patients With Type 2 Diabetes-Related Polyneuropathy Is Associated With Vascular Events and Mortality

July 23rd 2020

Our study found a significant association between pain in DPN and an increased risk of vascular events and mortality (Journal of Clinical Endocrinology & Metabolism)

 

Categories: Neuropathy, News
Tags: mortality, Type 2 Diabetes

Categories: Neuropathy
Tags: mortality, Type 2 Diabetes

Type 1 and Type 2 diabetes and COVID-19 related mortality in England: a cohort study in people with diabetes

May 20th 2020

Deaths in people with diabetes in England have more than doubled during the COVID-19 epidemic. Hyperglycaemia and obesity in both Type 1 and Type 2 diabetes were independently associated with increased COVID-19 mortality. Risk factor control could diminish the impact of COVID-19 in diabetes (NHS England)

Categories: News, Prevalence
Tags: COVID-19, mortality, Type 1 Diabetes, Type 2 Diabetes

Categories: Prevalence
Tags: COVID-19, mortality, Type 1 Diabetes, Type 2 Diabetes

Type 1 and Type 2 diabetes and COVID-19 related mortality in England: a whole population study

May 20th 2020

This nationwide analysis in England demonstrates that all types of diabetes are independently associated with a significant increased risk of in-hospital death with COVID-19 (NHS England)

Categories: News, Prevalence
Tags: COVID-19, mortality, Type 1 Diabetes, Type 2 Diabetes

Categories: Prevalence
Tags: COVID-19, mortality, Type 1 Diabetes, Type 2 Diabetes

Socio‐economic status and mortality in people with type 1 diabetes in Scotland 2006–2015: a retrospective cohort study

January 23rd 2020

Socio‐economic deprivation was associated with a steeper mortality gradient in people with type 1 diabetes than in the population without type 1 diabetes in Scotland. Age‐standardized mortality has decreased over time but socio‐economic inequalities may be increasing. (Diabetic Medicine)

Categories: Epidemiology, News
Tags: mortality, Scotland, Type 1 Diabetes

Categories: Epidemiology
Tags: mortality, Scotland, Type 1 Diabetes

Relationship Between Body Mass Index, Antidiabetic Agents, and Midterm Mortality in Patients With Both Type 2 Diabetes Mellitus and Acute Coronary Syndrome

March 27th 2019

In patients with type 2 diabetes mellitus and acute coronary syndrome, the relationship between body mass index and mortality rate is U‐shaped, with class I obesity representing the nadir and normal weight the peak. The protective effect of obesity disappeared in patients treated with insulin (JAHA)

Categories: News, Pathology
Tags: ACS, BMI, mortality, Type 2 Diabetes

Categories: Pathology
Tags: ACS, BMI, mortality, Type 2 Diabetes

The All-Cause Mortality and a Screening Tool to Determine High-Risk Patients among Prevalent Type 2 Diabetes Mellitus Patients

July 12th 2018

The model has moderate accuracy; the prognostic model can be used as a screening tool to classify T2DM patients who are at higher risk for mortality within five years (Journal of Diabetes Research)

Categories: News, Screening
Tags: mortality, Type 2 Diabetes

Categories: Screening
Tags: mortality, Type 2 Diabetes

Multiple risk factor control, mortality and cardiovascular events in type 2 diabetes and chronic kidney disease: a population-based cohort study

May 9th 2018

Multiple risk factor control (MRFC)  may lower the increased risks for mortality and cardiovascular events in people with diabetes and CKD (BMJ Open)

Categories: Nephropathy, News
Tags: mortality, risk factors, Type 2 Diabetes

Categories: Nephropathy
Tags: mortality, risk factors, Type 2 Diabetes

How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial

February 4th 2018

In this exploratory analysis from the EMPA-REG OUTCOME trial, changes in markers of plasma volume were the most important mediators of the reduction in risk of CV death with empagliflozin versus placebo (Diabetes Care)

Categories: Medication, News
Tags: EMPA-REG, Empagliflozin, mortality

Categories: Medication
Tags: EMPA-REG, Empagliflozin, mortality

Pioglitazone and cause-specific risk of mortality in patients with type 2 diabetes: extended analysis from a European multidatabase cohort study

January 20th 2018

This analysis suggests that pioglitazone is associated with a decrease in both cardiovascular and non-cardiovascular mortality. Results should be interpreted with caution due to the potential for residual confounding in this exploratory analysis. Further studies, specifically designed to test the association between pioglitazone use and patient-focused outcomes, are suggested (BMJ)

Categories: Medication, News
Tags: mortality, pioglitazone

Categories: Medication
Tags: mortality, pioglitazone

Fasting Glucose and All-Cause Mortality by Age in Diabetes: A Prospective Cohort Study

January 5th 2018

Optimal fasting glucose range for survival is higher in adults with than without known prevalent diabetes, except, perhaps, younger adults. Tight glucose control may lessen premature death in younger adults with diabetes. Hypoglycemia (<65 mg/dL) was associated with higher mortality than was fasting glucose 170–199 mg/dL, while fasting glucose 65–84 mg/dL had risks comparable with those at levels 140–169 mg/dL in diabetes (Diabetes Care)

Categories: Monitoring, News
Tags: fasting glucose, mortality

Categories: Monitoring
Tags: fasting glucose, mortality

Diabetes Is Not Associated With Increased 90-Day Mortality Risk in Critically Ill Patients With Sepsis

October 2nd 2017

In the current retrospective large database review, diabetes was not associated with adjusted 90-day mortality risk in critically ill patients admitted with sepsis (Critical Care Medicine)

Categories: News, Pathology
Tags: mortality, Sepsis

Categories: Pathology
Tags: mortality, Sepsis

National Diabetes Audit, 2015-16 Report 2: Complications and Mortality

July 13th 2017

This report from the National Diabetes Audit (NDA) covers complications of diabetes. It does not include diabetic eye disease or hypoglycaemia because presently there are no reliable records of these that the NDA can access. Most other cardiovascular and diabetes specific complications are included Download  (HQIP)

Categories: Audits, News
Tags: complications, mortality

Categories: Audits
Tags: complications, mortality

Inpatient screening for albuminuria and retinopathy to predict long-term mortality in type 2 diabetic patients

May 4th 2017

Albuminuria in type 2 diabetic inpatients is a strong predictor of long-term mortality after discharge from the hospital. Retinopathy is an independent predictor of mortality in type 2 diabetic inpatients without albuminuria but not in those with albuminuria. A low eGFR is a better predictor of mortality than retinopathy in type 2 diabetic inpatients with albuminuria (Diabetology & Metabolic Syndrome)

Categories: News, Screening
Tags: mortality, Type 2 Diabetes

Categories: Screening
Tags: mortality, Type 2 Diabetes

Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes

April 13th 2017

In Sweden from 1998 through 2014, mortality and the incidence of cardiovascular outcomes declined substantially among persons with diabetes, although fatal outcomes declined less among those with type 2 diabetes than among controls (NEJM)

Categories: Cardiovascular, News
Tags: mortality, Type 1 Diabetes, Type 2 Diabetes

Categories: Cardiovascular
Tags: mortality, Type 1 Diabetes, Type 2 Diabetes

Examining Trends in Type 2 Diabetes Incidence, Prevalence and Mortality in the UK between 2004 and 2014

April 7th 2017

The rising UK prevalence of type 2 diabetes over the last decade is likely to be explained by patients living longer rather than increasing type 2 diabetes incidence (Diabetes, Obesity and Metabolism)

Categories: News, Prevalence
Tags: mortality, Type 2 Diabetes

Categories: Prevalence
Tags: mortality, Type 2 Diabetes

Hemoglobin A1c and Mortality in Older Adults With and Without Diabetes: Results From the National Health and Nutrition Examination Surveys (1988–2011)

March 21st 2017

An HbA1c >8.0% was associated with increased risk of all-cause and cause-specific mortality in older adults with diabetes. Our results support the idea that better glycemic control is important for reducing mortality; however, in light of the conflicting evidence base, there is also a need for individualized glycemic targets for older adults with diabetes depending on their demographics, duration of diabetes, and existing comorbidities (Diabetes Care)

Categories: Monitoring, News
Tags: HbA1c, mortality

Categories: Monitoring
Tags: HbA1c, mortality

Nonlinear association of BMI with all-cause and cardiovascular mortality in type 2 diabetes mellitus

January 2nd 2017

In type 2 diabetes, BMI is nonlinearly associated with all-cause mortality with lowest risk in the overweight group in both men and women. Further research is needed to clarify the relationship with cardiovascular mortality and assess causality and sex differences (Diabetologia)

Categories: News, Obesity
Tags: BMI, mortality, Type 2 Diabetes

Categories: Obesity
Tags: BMI, mortality, Type 2 Diabetes
  • 1
  • 2
  • Next Page »

Subscribe

subscribe-iconFREE weekly updates by email Please CLICK HERE

Platinum Sponsors

Boehringer Ingelheim Lilly

Gold Sponsors

Novo NordiskNapp DiabetesAstraZeneca

Silver Sponsors

Abbott Diabetes CareWelsh Endocrinology and Diabetes Society (WEDS)About Ascensia Diabetes Care

FUNDING NOTICE

The Glycosmedia website and newsletter has been made possible with funding support from our sponsors. None of our sponsors have control over the content of the website, newsletter, apps, Twitter feed or RSS newsfeed.

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com

Advertisers

CRC Press

The organisations advertising in this section do not have any input into, or editorial control over the content of this website.

Categories

  • Audits
  • Bariatric
  • Biochemistry
  • Cardiovascular
  • Devices
  • Diagnosis
  • Diet
  • Education
  • Epidemiology
  • Genetics
  • Gestational
  • Guidance
  • Guidelines
  • Hepatology
  • Hypertension
  • Immunology
  • Management
  • Media
  • Medication
  • Meetings
  • Monitoring
  • Nephrology
  • Neuropathy
  • Nephropathy
  • Obesity
  • Ophthalmology
  • Paediatrics
  • Pathology
  • Pharma
  • Pharmacology
  • Physiology
  • Podiatry
  • Prediabetes
  • Prevalence
  • Prevention
  • Psychological
  • Reports
  • Research
  • Screening
  • Sponsorship
  • Technology
  • Testing
  • Transplantation
  • Treatment
  • Wound Care

To see all articles associated with a category just click on the category name.

Popular Tags

ADA BMI canagliflozin CGM CKD closed-loop COVID-19 dapagliflozin DPP4 elderly Empagliflozin exenatide exercise GLP1 glycaemic control HbA1c heart failure hyperglycemia hypoglycemia incretin insulin insulin pump Insulin resistance Ketoacidosis lada liraglutide metformin microvascular mortality NICE pioglitazone retinopathy semaglutide SGLT2 inhibitors sitagliptin statin sulfonylureas Type 1 Diabetes Type 2 Diabetes Vitamin D

To see all articles associated with a tag just click on the tag name.

Complete list of Tags ››

Join us on Facebook

Join us on Facebook

Please share Glycosmedia:

Follow us on Twitter

My Tweets

mobileGlycosmedia is also available as an App:

For iPhone and iPad | For Android devices


Sponsorship and Advertising

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com

Copyright © 2021 Glycosmedia Partnership